- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Blood-Brain Barrier Transport Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Blood-Brain Barrier Transport Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Alzheimer's Disease accounting for % of the Blood-Brain Barrier Transport Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Carrier-mediated Transport segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Blood-Brain Barrier Transport Drugs include Cyclenium, BioAdvance, EIP Pharma, Bioasis, and Immune Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Blood-Brain Barrier Transport Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others
Market segment by Application can be divided into
Alzheimer's Disease
Epilepsy
Parkinson's Disease
Multiple Sclerosis
Hunter's Syndrome
Brain Cancer
Others
The key market players for global Blood-Brain Barrier Transport Drugs market are listed below:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood-Brain Barrier Transport Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Blood-Brain Barrier Transport Drugs, with price, sales, revenue and global market share of Blood-Brain Barrier Transport Drugs from 2019 to 2022.
Chapter 3, the Blood-Brain Barrier Transport Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood-Brain Barrier Transport Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Blood-Brain Barrier Transport Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood-Brain Barrier Transport Drugs.
Chapter 13, 14, and 15, to describe Blood-Brain Barrier Transport Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Blood-Brain Barrier Transport Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blood-Brain Barrier Transport Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Carrier-mediated Transport
1.2.3 Receptor-mediated Transport
1.2.4 Absorptive-mediated Transport
1.2.5 Active Efflux Transport
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Blood-Brain Barrier Transport Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Alzheimer's Disease
1.3.3 Epilepsy
1.3.4 Parkinson's Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter's Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Global Blood-Brain Barrier Transport Drugs Market Size & Forecast
1.4.1 Global Blood-Brain Barrier Transport Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Blood-Brain Barrier Transport Drugs Sales in Volume (2017-2028)
1.4.3 Global Blood-Brain Barrier Transport Drugs Price (2017-2028)
1.5 Global Blood-Brain Barrier Transport Drugs Production Capacity Analysis
1.5.1 Global Blood-Brain Barrier Transport Drugs Total Production Capacity (2017-2028)
1.5.2 Global Blood-Brain Barrier Transport Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Blood-Brain Barrier Transport Drugs Market Drivers
1.6.2 Blood-Brain Barrier Transport Drugs Market Restraints
1.6.3 Blood-Brain Barrier Transport Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Cyclenium
2.1.1 Cyclenium Details
2.1.2 Cyclenium Major Business
2.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Product and Services
2.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BioAdvance
2.2.1 BioAdvance Details
2.2.2 BioAdvance Major Business
2.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Product and Services
2.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 EIP Pharma
2.3.1 EIP Pharma Details
2.3.2 EIP Pharma Major Business
2.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Product and Services
2.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bioasis
2.4.1 Bioasis Details
2.4.2 Bioasis Major Business
2.4.3 Bioasis Blood-Brain Barrier Transport Drugs Product and Services
2.4.4 Bioasis Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Immune Pharmaceuticals
2.5.1 Immune Pharmaceuticals Details
2.5.2 Immune Pharmaceuticals Major Business
2.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product and Services
2.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AZ Therapies
2.6.1 AZ Therapies Details
2.6.2 AZ Therapies Major Business
2.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Product and Services
2.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Palobiofarma
2.7.1 Palobiofarma Details
2.7.2 Palobiofarma Major Business
2.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Product and Services
2.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bach Pharma
2.8.1 Bach Pharma Details
2.8.2 Bach Pharma Major Business
2.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Product and Services
2.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BrainsGate
2.9.1 BrainsGate Details
2.9.2 BrainsGate Major Business
2.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Product and Services
2.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CarThera
2.10.1 CarThera Details
2.10.2 CarThera Major Business
2.10.3 CarThera Blood-Brain Barrier Transport Drugs Product and Services
2.10.4 CarThera Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Dainippon Sumitomo Pharma
2.11.1 Dainippon Sumitomo Pharma Details
2.11.2 Dainippon Sumitomo Pharma Major Business
2.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product and Services
2.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Fluorinov Pharma
2.12.1 Fluorinov Pharma Details
2.12.2 Fluorinov Pharma Major Business
2.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product and Services
2.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Fondazione Telethon
2.13.1 Fondazione Telethon Details
2.13.2 Fondazione Telethon Major Business
2.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Product and Services
2.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Minoryx
2.14.1 Minoryx Details
2.14.2 Minoryx Major Business
2.14.3 Minoryx Blood-Brain Barrier Transport Drugs Product and Services
2.14.4 Minoryx Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 NewGen Therapeutics
2.15.1 NewGen Therapeutics Details
2.15.2 NewGen Therapeutics Major Business
2.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product and Services
2.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Blood-Brain Barrier Transport Drugs Breakdown Data by Manufacturer
3.1 Global Blood-Brain Barrier Transport Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Blood-Brain Barrier Transport Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Blood-Brain Barrier Transport Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Blood-Brain Barrier Transport Drugs Manufacturer Market Share in 2021
3.5 Global Blood-Brain Barrier Transport Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Blood-Brain Barrier Transport Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Blood-Brain Barrier Transport Drugs Market Size by Region
4.1.1 Global Blood-Brain Barrier Transport Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2028)
4.2 North America Blood-Brain Barrier Transport Drugs Revenue (2017-2028)
4.3 Europe Blood-Brain Barrier Transport Drugs Revenue (2017-2028)
4.4 Asia-Pacific Blood-Brain Barrier Transport Drugs Revenue (2017-2028)
4.5 South America Blood-Brain Barrier Transport Drugs Revenue (2017-2028)
4.6 Middle East and Africa Blood-Brain Barrier Transport Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Blood-Brain Barrier Transport Drugs Sales in Volume by Type (2017-2028)
5.2 Global Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2028)
5.3 Global Blood-Brain Barrier Transport Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Blood-Brain Barrier Transport Drugs Sales in Volume by Application (2017-2028)
6.2 Global Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2028)
6.3 Global Blood-Brain Barrier Transport Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
7.2 North America Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
7.3 North America Blood-Brain Barrier Transport Drugs Market Size by Country
7.3.1 North America Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
8.2 Europe Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
8.3 Europe Blood-Brain Barrier Transport Drugs Market Size by Country
8.3.1 Europe Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size by Region
9.3.1 Asia-Pacific Blood-Brain Barrier Transport Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
10.2 South America Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
10.3 South America Blood-Brain Barrier Transport Drugs Market Size by Country
10.3.1 South America Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Blood-Brain Barrier Transport Drugs Market Size by Country
11.3.1 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Blood-Brain Barrier Transport Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Blood-Brain Barrier Transport Drugs
12.3 Blood-Brain Barrier Transport Drugs Production Process
12.4 Blood-Brain Barrier Transport Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Blood-Brain Barrier Transport Drugs Typical Distributors
13.3 Blood-Brain Barrier Transport Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Blood-Brain Barrier Transport Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Blood-Brain Barrier Transport Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Cyclenium Basic Information, Manufacturing Base and Competitors
Table 4. Cyclenium Major Business
Table 5. Cyclenium Blood-Brain Barrier Transport Drugs Product and Services
Table 6. Cyclenium Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BioAdvance Basic Information, Manufacturing Base and Competitors
Table 8. BioAdvance Major Business
Table 9. BioAdvance Blood-Brain Barrier Transport Drugs Product and Services
Table 10. BioAdvance Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. EIP Pharma Basic Information, Manufacturing Base and Competitors
Table 12. EIP Pharma Major Business
Table 13. EIP Pharma Blood-Brain Barrier Transport Drugs Product and Services
Table 14. EIP Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bioasis Basic Information, Manufacturing Base and Competitors
Table 16. Bioasis Major Business
Table 17. Bioasis Blood-Brain Barrier Transport Drugs Product and Services
Table 18. Bioasis Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Immune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Immune Pharmaceuticals Major Business
Table 21. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product and Services
Table 22. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AZ Therapies Basic Information, Manufacturing Base and Competitors
Table 24. AZ Therapies Major Business
Table 25. AZ Therapies Blood-Brain Barrier Transport Drugs Product and Services
Table 26. AZ Therapies Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Palobiofarma Basic Information, Manufacturing Base and Competitors
Table 28. Palobiofarma Major Business
Table 29. Palobiofarma Blood-Brain Barrier Transport Drugs Product and Services
Table 30. Palobiofarma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bach Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Bach Pharma Major Business
Table 33. Bach Pharma Blood-Brain Barrier Transport Drugs Product and Services
Table 34. Bach Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BrainsGate Basic Information, Manufacturing Base and Competitors
Table 36. BrainsGate Major Business
Table 37. BrainsGate Blood-Brain Barrier Transport Drugs Product and Services
Table 38. BrainsGate Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CarThera Basic Information, Manufacturing Base and Competitors
Table 40. CarThera Major Business
Table 41. CarThera Blood-Brain Barrier Transport Drugs Product and Services
Table 42. CarThera Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Dainippon Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Dainippon Sumitomo Pharma Major Business
Table 45. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product and Services
Table 46. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Fluorinov Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Fluorinov Pharma Major Business
Table 49. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product and Services
Table 50. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Fondazione Telethon Basic Information, Manufacturing Base and Competitors
Table 52. Fondazione Telethon Major Business
Table 53. Fondazione Telethon Blood-Brain Barrier Transport Drugs Product and Services
Table 54. Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Minoryx Basic Information, Manufacturing Base and Competitors
Table 56. Minoryx Major Business
Table 57. Minoryx Blood-Brain Barrier Transport Drugs Product and Services
Table 58. Minoryx Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. NewGen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. NewGen Therapeutics Major Business
Table 61. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product and Services
Table 62. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Blood-Brain Barrier Transport Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 64. Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Blood-Brain Barrier Transport Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Blood-Brain Barrier Transport Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 67. Head Office and Blood-Brain Barrier Transport Drugs Production Site of Key Manufacturer
Table 68. Blood-Brain Barrier Transport Drugs New Entrant and Capacity Expansion Plans
Table 69. Blood-Brain Barrier Transport Drugs Mergers & Acquisitions in the Past Five Years
Table 70. Global Blood-Brain Barrier Transport Drugs Sales by Region (2017-2022) & (K Pcs)
Table 71. Global Blood-Brain Barrier Transport Drugs Sales by Region (2023-2028) & (K Pcs)
Table 72. Global Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Blood-Brain Barrier Transport Drugs Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)
Table 75. Global Blood-Brain Barrier Transport Drugs Sales by Type (2023-2028) & (K Pcs)
Table 76. Global Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Blood-Brain Barrier Transport Drugs Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Blood-Brain Barrier Transport Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 79. Global Blood-Brain Barrier Transport Drugs Price by Type (2023-2028) & (USD/Pcs)
Table 80. Global Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)
Table 81. Global Blood-Brain Barrier Transport Drugs Sales by Application (2023-2028) & (K Pcs)
Table 82. Global Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Blood-Brain Barrier Transport Drugs Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Blood-Brain Barrier Transport Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 85. Global Blood-Brain Barrier Transport Drugs Price by Application (2023-2028) & (USD/Pcs)
Table 86. North America Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022) & (K Pcs)
Table 87. North America Blood-Brain Barrier Transport Drugs Sales by Country (2023-2028) & (K Pcs)
Table 88. North America Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Blood-Brain Barrier Transport Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)
Table 91. North America Blood-Brain Barrier Transport Drugs Sales by Type (2023-2028) & (K Pcs)
Table 92. North America Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)
Table 93. North America Blood-Brain Barrier Transport Drugs Sales by Application (2023-2028) & (K Pcs)
Table 94. Europe Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022) & (K Pcs)
Table 95. Europe Blood-Brain Barrier Transport Drugs Sales by Country (2023-2028) & (K Pcs)
Table 96. Europe Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Blood-Brain Barrier Transport Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)
Table 99. Europe Blood-Brain Barrier Transport Drugs Sales by Type (2023-2028) & (K Pcs)
Table 100. Europe Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)
Table 101. Europe Blood-Brain Barrier Transport Drugs Sales by Application (2023-2028) & (K Pcs)
Table 102. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Region (2017-2022) & (K Pcs)
Table 103. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Region (2023-2028) & (K Pcs)
Table 104. Asia-Pacific Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Blood-Brain Barrier Transport Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)
Table 107. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Type (2023-2028) & (K Pcs)
Table 108. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)
Table 109. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales by Application (2023-2028) & (K Pcs)
Table 110. South America Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022) & (K Pcs)
Table 111. South America Blood-Brain Barrier Transport Drugs Sales by Country (2023-2028) & (K Pcs)
Table 112. South America Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Blood-Brain Barrier Transport Drugs Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)
Table 115. South America Blood-Brain Barrier Transport Drugs Sales by Type (2023-2028) & (K Pcs)
Table 116. South America Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)
Table 117. South America Blood-Brain Barrier Transport Drugs Sales by Application (2023-2028) & (K Pcs)
Table 118. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Region (2017-2022) & (K Pcs)
Table 119. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Region (2023-2028) & (K Pcs)
Table 120. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)
Table 123. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Type (2023-2028) & (K Pcs)
Table 124. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)
Table 125. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Application (2023-2028) & (K Pcs)
Table 126. Blood-Brain Barrier Transport Drugs Raw Material
Table 127. Key Manufacturers of Blood-Brain Barrier Transport Drugs Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Blood-Brain Barrier Transport Drugs Typical Distributors
Table 131. Blood-Brain Barrier Transport Drugs Typical Customers
List of Figures
Figure 1. Blood-Brain Barrier Transport Drugs Picture
Figure 2. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type in 2021
Figure 3. Carrier-mediated Transport
Figure 4. Receptor-mediated Transport
Figure 5. Absorptive-mediated Transport
Figure 6. Active Efflux Transport
Figure 7. Others
Figure 8. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application in 2021
Figure 9. Alzheimer's Disease
Figure 10. Epilepsy
Figure 11. Parkinson's Disease
Figure 12. Multiple Sclerosis
Figure 13. Hunter's Syndrome
Figure 14. Brain Cancer
Figure 15. Others
Figure 16. Global Blood-Brain Barrier Transport Drugs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 17. Global Blood-Brain Barrier Transport Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Blood-Brain Barrier Transport Drugs Sales (2017-2028) & (K Pcs)
Figure 19. Global Blood-Brain Barrier Transport Drugs Price (2017-2028) & (USD/Pcs)
Figure 20. Global Blood-Brain Barrier Transport Drugs Production Capacity (2017-2028) & (K Pcs)
Figure 21. Global Blood-Brain Barrier Transport Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Blood-Brain Barrier Transport Drugs Market Drivers
Figure 23. Blood-Brain Barrier Transport Drugs Market Restraints
Figure 24. Blood-Brain Barrier Transport Drugs Market Trends
Figure 25. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Blood-Brain Barrier Transport Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Blood-Brain Barrier Transport Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Blood-Brain Barrier Transport Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Blood-Brain Barrier Transport Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Blood-Brain Barrier Transport Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Blood-Brain Barrier Transport Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Blood-Brain Barrier Transport Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 40. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Blood-Brain Barrier Transport Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Blood-Brain Barrier Transport Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Blood-Brain Barrier Transport Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Blood-Brain Barrier Transport Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Blood-Brain Barrier Transport Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Blood-Brain Barrier Transport Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs in 2021
Figure 84. Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
Figure 85. Blood-Brain Barrier Transport Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
